Vext Science, Inc.
VEXTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $64 | $31 | $31 | $20 |
| - Cash | $4 | $5 | $5 | $5 |
| + Debt | $35 | $36 | $37 | $40 |
| Enterprise Value | $96 | $62 | $63 | $55 |
| Revenue | $13 | $13 | $12 | $10 |
| % Growth | -5.5% | 16% | 13.4% | – |
| Gross Profit | $4 | $5 | $2 | $2 |
| % Margin | 31.3% | 36.3% | 19.7% | 20.9% |
| EBITDA | $2 | $5 | $1 | -$2 |
| % Margin | 14.8% | 39.6% | 8.7% | -19.7% |
| Net Income | -$3 | -$1 | -$3 | -$9 |
| % Margin | -20.7% | -11% | -28.8% | -90.4% |
| EPS Diluted | -0.011 | -0.006 | -0.014 | -0.05 |
| % Growth | -72.1% | 54.8% | 72.8% | – |
| Operating Cash Flow | $1 | $4 | $3 | $4 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $0 | $3 | $2 | $3 |